Philip Morris International Submits Applications To Commercialize IQOS ILUMA Tobacco Heating System To U.S. FDA
Portfolio Pulse from Benzinga Newsdesk
Philip Morris International (PMI) has submitted applications to the U.S. FDA to commercialize its IQOS ILUMA heated tobacco products. The company is seeking an order to market these products as modified risk products that reduce exposure to harmful chemicals. IQOS ILUMA products are currently available in 27 international markets and have demonstrated higher rates of full switching by adults who smoke. PMI will have full rights to commercialize all IQOS products in the U.S. as of April 30, 2024, per an agreement with Altria Group.
October 20, 2023 | 8:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Philip Morris International's move to commercialize IQOS ILUMA in the U.S. could potentially increase its market share and revenues.
The commercialization of IQOS ILUMA in the U.S. could potentially increase Philip Morris International's market share and revenues. The company's innovative product, which is already available in 27 international markets, has demonstrated higher rates of full switching by adults who smoke. This could attract more consumers in the U.S., leading to increased sales and revenues.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100